Guo Q, Qin H, Chen Z, Zhang W, Zheng L, Qin T
Genes Dis. 2025; 12(3):101311.
PMID: 40034124
PMC: 11875185.
DOI: 10.1016/j.gendis.2024.101311.
Blaszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A
Cancers (Basel). 2025; 17(2).
PMID: 39858010
PMC: 11764116.
DOI: 10.3390/cancers17020228.
Liu Y, Zou Y, Ye Y, Chen Y
Cancer Med. 2024; 13(22):e70410.
PMID: 39558881
PMC: 11574469.
DOI: 10.1002/cam4.70410.
Sat-Munoz D, Balderas-Pena L, Gomez-Sanchez E, Martinez-Herrera B, Trujillo-Hernandez B, Quiroga-Morales L
Int J Mol Sci. 2024; 25(18).
PMID: 39337467
PMC: 11432412.
DOI: 10.3390/ijms25189979.
Rodvold J, Grimmer M, Ruiz K, Marsters S, Oikonomidi I, Tan-Aristy E
Cancer Res Commun. 2024; 4(10):2734-2755.
PMID: 39324706
PMC: 11492184.
DOI: 10.1158/2767-9764.CRC-24-0268.
Intricate relationship between cancer stemness, metastasis, and drug resistance.
Dakal T, Bhushan R, Xu C, Gadi B, Cameotra S, Yadav V
MedComm (2020). 2024; 5(10):e710.
PMID: 39309691
PMC: 11416093.
DOI: 10.1002/mco2.710.
Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ.
Powala K, Zolek T, Brown G, Kutner A
Int J Mol Sci. 2024; 25(12).
PMID: 38928275
PMC: 11203493.
DOI: 10.3390/ijms25126568.
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.
Worley J, Noh H, You D, Turunen M, Ding H, Paull E
bioRxiv. 2024; .
PMID: 38798673
PMC: 11118419.
DOI: 10.1101/2023.11.08.562798.
Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.
Pandya P, Al-Qasrawi D, Klinge S, Justilien V
Front Immunol. 2024; 15:1369356.
PMID: 38765006
PMC: 11099288.
DOI: 10.3389/fimmu.2024.1369356.
Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease.
Pan H, Ho S, Xue C, Cui J, Johanson Q, Sachs N
Circulation. 2024; 149(24):1885-1898.
PMID: 38686559
PMC: 11164647.
DOI: 10.1161/CIRCULATIONAHA.123.067587.
Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway.
Heisnam R, Devi S, Mohanty S, Mukherjee P, Rayala V, Radhakrishnanand P
Am J Cancer Res. 2024; 14(3):1071-1086.
PMID: 38590426
PMC: 10998759.
DOI: 10.62347/JTNQ4812.
Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy.
Belgiovine C, Mebelli K, Raffaele A, De Cicco M, Rotella J, Pedrazzoli P
Int J Mol Sci. 2024; 25(6).
PMID: 38542199
PMC: 10970338.
DOI: 10.3390/ijms25063225.
TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R, Cao Y, Wang Y, Zhao T, Yang K, Fan M
Breast Cancer Res. 2024; 26(1):48.
PMID: 38504374
PMC: 10949598.
DOI: 10.1186/s13058-024-01802-z.
The CK1ε/SIAH1 axis regulates AXIN1 stability in colorectal cancer cells.
Yan M, Su Z, Pang X, Wang H, Dai H, Ning J
Mol Oncol. 2024; 18(9):2277-2297.
PMID: 38419282
PMC: 11467792.
DOI: 10.1002/1878-0261.13624.
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression.
Strippoli R, Niayesh-Mehr R, Adelipour M, Khosravi A, Cordani M, Zarrabi A
Cancers (Basel). 2024; 16(4).
PMID: 38398197
PMC: 10886827.
DOI: 10.3390/cancers16040807.
Targeting Cervical Cancer Stem Cells by Phytochemicals.
Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A
Curr Med Chem. 2024; 31(32):5222-5254.
PMID: 38288813
DOI: 10.2174/0109298673281823231222065616.
The E3 ligase HUWE1 increases the sensitivity of CRC to oxaliplatin through TOMM20 degradation.
Lee C, Park S, Yoon S
Oncogene. 2024; 43(9):636-649.
PMID: 38184713
DOI: 10.1038/s41388-023-02928-8.
Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.
Ei Z, Racha S, Yokoya M, Hotta D, Zou H, Chanvorachote P
Mar Drugs. 2023; 21(12).
PMID: 38132948
PMC: 10744608.
DOI: 10.3390/md21120627.
Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly M, Cox A, Haney M, Zhang W, Arvin E, Sampathi S
Biomed Pharmacother. 2023; 170:116013.
PMID: 38104416
PMC: 10833092.
DOI: 10.1016/j.biopha.2023.116013.
LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer.
Mehdawi L, Ghatak S, Chakraborty P, Sjolander A, Andersson T
Cells. 2023; 12(22).
PMID: 37998393
PMC: 10670301.
DOI: 10.3390/cells12222658.